Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check3 days agoChange DetectedAdded history entries for versions 306–309, documenting updates to Study Status and Contacts/Locations dated 2026-03-07 to 2026-03-12.SummaryDifference0.2%

- Check10 days agoChange DetectedAdded 2026-03-03 to 2026-03-06 Study Status entries and Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.3%

- Check17 days agoChange DetectedNew history entries were added showing updates to the Study Status and new version numbers (296–300) for the record.SummaryDifference0.2%

- Check24 days agoChange DetectedThe study record shows a new Recruiting status and the addition of core sections (Study Status, Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Study Identification, Recruitment Status) with dates 2026-02-14 to 2026-02-20. The prior note 'Awaiting amendment to add new cohort' was removed.SummaryDifference0.4%

- Check32 days agoChange DetectedA new site revision v3.4.2 was added to the history and the previous revision v3.4.1 was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedA new Study Status section was added with multiple entries, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.